Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,138 | 154 | 98.5% |
| Travel and Lodging | $62.50 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $698.77 | 40 | $0 (2024) |
| GENZYME CORPORATION | $669.51 | 21 | $0 (2024) |
| Stryker Corporation | $648.62 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $548.15 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $403.37 | 22 | $0 (2022) |
| Entellus Medical, Inc. | $226.94 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $180.85 | 5 | $0 (2023) |
| Acclarent, Inc | $162.18 | 2 | $0 (2017) |
| ALK-Abello, Inc | $113.12 | 2 | $0 (2021) |
| Medtronic, Inc. | $93.98 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $718.23 | 39 | GlaxoSmithKline, LLC. ($239.28) |
| 2023 | $657.08 | 28 | GENZYME CORPORATION ($263.17) |
| 2022 | $470.84 | 26 | GlaxoSmithKline, LLC. ($136.04) |
| 2021 | $614.97 | 25 | Novartis Pharmaceuticals Corporation ($142.78) |
| 2020 | $169.51 | 5 | Regeneron Healthcare Solutions, Inc. ($94.61) |
| 2019 | $622.12 | 11 | Stryker Corporation ($510.10) |
| 2018 | $529.03 | 13 | Optinose US, Inc. ($182.88) |
| 2017 | $418.55 | 8 | Acclarent, Inc ($162.18) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology and Neurology | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Immunology and Neurology | ||||||
| 08/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Allergy | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Immunology and Neurology | ||||||
| 05/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,117 | 1,367 | $479,621 | $136,097 |
| 2022 | 7 | 1,004 | 1,387 | $502,296 | $140,137 |
| 2021 | 6 | 820 | 1,334 | $486,440 | $134,293 |
| 2020 | 10 | 1,027 | 1,419 | $511,340 | $128,007 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 244 | 309 | $236,694 | $51,505 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 318 | 455 | $98,735 | $35,483 | 35.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 165 | 165 | $33,000 | $15,480 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 128 | $28,800 | $14,734 | 51.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 82 | 85 | $24,650 | $9,525 | 38.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 121 | 150 | $45,300 | $4,713 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,120 | $2,351 | 38.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 58 | 58 | $6,322 | $2,305 | 36.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 230 | 338 | $243,944 | $57,657 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 336 | 520 | $126,170 | $41,599 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 124 | $31,000 | $14,919 | 48.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 104 | 104 | $28,940 | $10,197 | 35.2% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 57 | 62 | $21,730 | $7,533 | 34.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 151 | 216 | $47,833 | $7,169 | 15.0% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 23 | 23 | $2,679 | $1,063 | 39.7% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 191 | 325 | $221,000 | $58,198 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 327 | 575 | $149,500 | $46,799 | 31.3% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 150 | 250 | $43,750 | $8,522 | 19.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 83 | 83 | $31,955 | $8,477 | 26.5% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 45 | 53 | $21,995 | $6,346 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 48 | $18,240 | $5,950 | 32.6% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2020 | 211 | 305 | $207,400 | $53,466 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 374 | 578 | $150,655 | $38,624 | 25.6% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2020 | 82 | 90 | $37,350 | $10,341 | 27.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 174 | 247 | $43,225 | $7,844 | 18.1% |
About Dr. Alan Cohen, MD
Dr. Alan Cohen, MD is a Otolaryngology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295793545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Cohen, MD has received a total of $4,200 in payments from pharmaceutical and medical device companies, with $718.23 received in 2024. These payments were reported across 155 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,138).
As a Medicare-enrolled provider, Cohen has provided services to 3,968 Medicare beneficiaries, totaling 5,507 services with total Medicare billing of $538,534. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Bronx, NY
- Active Since 05/03/2006
- Last Updated 06/28/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1295793545
Products in Payments
- DUPIXENT (Biological) $850.36
- Xhance (Drug) $698.77
- NUCALA (Biological) $548.15
- XOLAIR (Biological) $403.37
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $355.36
- CLARIFIX (Device) $263.00
- ACCLARENT Balloon Inflation Device (Device) $142.60
- NSE - NASOPORE OTOPORE (Device) $123.18
- XprESS Multi-Sinus Dilation System (Device) $118.68
- Otiprio (Drug) $97.41
- PROPEL (Device) $93.09
- AUVI-Q (Drug) $65.34
- Xembify (Biological) $64.15
- Ryaltris (Drug) $62.44
- NUVENT (Device) $57.92
- Sinuva (Drug) $36.06
- Dymista (Drug) $29.91
- RINVOQ (Biological) $28.20
- INSPIRE (Device) $25.13
- RELIEVA SCOUT Multi-Sinus Dilation System (Device) $19.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Bronx
Ronda Alexander, Md, MD
Otolaryngology — Payments: $37,779
Marvin Fried, Md, MD
Otolaryngology — Payments: $20,589
Dr. Harrison Glassman, Md, MD
Otolaryngology — Payments: $9,006
Dr. Bradley Schiff, M.d, M.D
Otolaryngology — Payments: $4,851
John Naughton
Otolaryngology — Payments: $4,676
Dr. Steven Goldstein, M.d, M.D
Otolaryngology — Payments: $4,088